Published in Reprod Biol Endocrinol on April 22, 2009
Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. Fertil Steril (2013) 1.26
A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod (2012) 1.05
The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol (2012) 0.98
Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci (2014) 0.85
A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles. J Hum Reprod Sci (2011) 0.84
The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles. J Assist Reprod Genet (2014) 0.82
Proceedings from the conference on Reproductive Problems in Women of Color. Fertil Steril (2010) 0.80
Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium. Int J Reprod Biomed (Yazd) (2016) 0.78
Dilatation and curettage effect on the endometrial thickness. Iran Red Crescent Med J (2013) 0.77
Endometrial Receptivity and its Predictive Value for IVF/ICSI-Outcome. Geburtshilfe Frauenheilkd (2012) 0.76
Efficacy of Intrauterine infusion of granulocyte colony stimulating factor on patients with history of implantation failure: A randomized control trial. Int J Reprod Biomed (Yazd) (2016) 0.75
Association between follicular fluid levels of HMGB1 protein and outcomes in patients undergoing in vitro fertilization/intracytoplasmic sperm injection cycles. Exp Ther Med (2015) 0.75
A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome. Exp Ther Med (2015) 0.75
The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response. PLoS One (2015) 0.75
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72
Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) (2007) 2.68
Fertility and ageing. Hum Reprod Update (2005) 2.68
In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med (2006) 2.41
Body mass index and uterine receptivity in the oocyte donation model. Fertil Steril (2003) 2.24
Pregnancy outcome after blastocyst transfer as compared to early cleavage stage embryo transfer. Hum Reprod (2004) 1.85
Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod (2004) 1.85
Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev (2007) 1.78
Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril (2001) 1.76
Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity (Silver Spring) (2008) 1.68
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril (2005) 1.60
Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril (2006) 1.52
Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update (2008) 1.50
Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril (2007) 1.50
The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod (2003) 1.47
Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program. Fertil Steril (2000) 1.41
Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertil Steril (2006) 1.40
Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril (2005) 1.39
Uterine contractility decreases at the time of blastocyst transfers. Hum Reprod (2001) 1.38
Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril (2003) 1.30
Increased body mass index has a deleterious effect on in vitro fertilization outcome. J Assist Reprod Genet (2001) 1.27
Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand (2000) 1.26
Epidemiology of endometriosis among parous women. Obstet Gynecol (1995) 1.24
Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod (2007) 1.14
Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern. Eur J Obstet Gynecol Reprod Biol (2005) 1.14
Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril (2000) 1.14
The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod (1999) 1.10
Changes in measured endometrial thickness predict in vitro fertilization success. Fertil Steril (2007) 1.00
Endometriosis in the black woman. Am J Obstet Gynecol (1976) 0.98
Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 versus day 5. Fertil Steril (2007) 0.93
Blastocyst-endometrial interaction: an appraisal of some old and new ideas. Mol Hum Reprod (1996) 0.91
Endometriosis and race. Aust N Z J Obstet Gynaecol (1992) 0.89
Ultrasonography as a predictor of embryo implantation after in vitro fertilization: a controlled study. Fertil Steril (2003) 0.87
Validity of the in vitro fertilisation league tables: influence of patients' characteristics. BJOG (2007) 0.81
The process of decision making in reproductive medicine. Semin Reprod Med (2005) 0.80
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 3.57
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod (2009) 2.26
Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol (2008) 2.15
Implications of blood type for ovarian reserve. Hum Reprod (2011) 1.78
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause (2009) 1.64
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril (2008) 1.64
Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women. Gynecol Oncol (2010) 1.64
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause (2015) 1.61
Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause (2008) 1.54
Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues (2005) 1.52
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health (2008) 1.47
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab (2002) 1.47
Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care (2004) 1.45
Assessing comprehension of clinical research. Contemp Clin Trials (2011) 1.44
Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation. Menopause (2015) 1.39
Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril (2009) 1.36
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab (2012) 1.24
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab (2009) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18
Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Ethn Dis (2010) 1.16
The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15
Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond Engl) (2009) 1.14
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab (2006) 1.14
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet (2010) 1.12
Relevance of vitamin D in reproduction. Hum Reprod (2012) 1.09
Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med (2005) 1.08
Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol (2010) 1.08
Age-related decline in fertility. Endocrinol Metab Clin North Am (2003) 1.08
Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05
Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women. J Clin Endocrinol Metab (2014) 1.05
Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism (2003) 1.03
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril (2008) 1.02
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02
Predictors of chronic disease at midlife and beyond--the health risks of obesity. Maturitas (2009) 1.00
Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99
Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril (2008) 0.99
Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98
The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol (2008) 0.97
Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev (2002) 0.95
Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol (2014) 0.95
The nucleolar channel system of human endometrium is related to endoplasmic reticulum and R-rings. Mol Biol Cell (2007) 0.95
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
High prevalence of vitamin D deficiency in Pakistani mothers and their newborns. Int J Gynaecol Obstet (2011) 0.93
The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab (2003) 0.92
The Women's Health Initiative: an unforgettable decade. Menopause (2012) 0.92
Postthaw blastomere survival is predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril (2004) 0.89
The reproductive endocrinology of the menopausal transition. Steroids (2011) 0.89
Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN). Fertil Steril (2009) 0.89
Declining ovarian reserve adversely influences granulosa cell viability. Fertil Steril (2008) 0.88
Cardiovascular disease and ovarian function. Curr Opin Obstet Gynecol (2011) 0.88
Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci (2010) 0.88
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause (2008) 0.88
Association Between Statin Use and Endometrial Cancer Survival. Obstet Gynecol (2015) 0.87
Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab (2014) 0.87
Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab (2012) 0.86
Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol (2012) 0.86
Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR. Fertil Steril (2007) 0.86
Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci (2008) 0.86
Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril (2008) 0.86
Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod (2009) 0.86
Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab (2008) 0.86
A decade after the Women's Health Initiative--the experts do agree. Fertil Steril (2012) 0.86
Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
Diminished ovarian reserve in a woman with a balanced 13;21 translocation. Fertil Steril (2008) 0.85
Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance. Am J Physiol Endocrinol Metab (2011) 0.85
Assessment of luteal function in the vervet monkey as a means to develop a model for obesity-related reproductive phenotype. Syst Biol Reprod Med (2013) 0.84
Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) (2013) 0.84
Differential granulosa cell gene expression in young women with diminished ovarian reserve. Reprod Sci (2011) 0.84
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Perspective on hormone therapy 10 years after the WHI. Maturitas (2013) 0.83
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83